For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable vision loss. The risk: cancer.

Aging, at its most fundamental level, is a molecular process. Chemical marks on the genome shift and lose fidelity over time, ...

A new international clinical intervention study published in Clinical Nutrition reveals the molecular and transcriptomic mechanisms through which a dietary intervention may beneficially influence gene ...

Butyrate, produced when gut bacteria ferment dietary fiber, was shown to influence immune-cell identity, trafficking, and ...

First human gets experimental gene shot to rewind ageing cells in the eye Life Biosciences has dosed its first patient with ER-100, a treatment that uses partial cellular reprogramming to target ...

HTX-001 is a first-in-class antisense oligonucleotide designed to downregulate WISPER lncRNA, a driver of fibrosis in the heart Phase 1a/b trial to evaluate the safety and tolerability of HTX-001 in ...

HAYA Therapeutics Announces First Cohort Dosed in Phase 1 Clinical Trial of HTX-001, an Investigational Precision Cellular Reprogramming Therapy for Cardiac Fibrosis HTX-001 is a first-in-class ...

Gear-obsessed editors choose every product we review. We may earn commission if you buy from a link. Why Trust Us? Here’s what you’ll learn when you read this story: A scientist wants to reprogram ...

Yuancheng Ryan Lu could barely breathe while he waited for his labmate to adjust the microscope focus. On the slide in front of them were the results of Lu’s latest attempt to turn back time for ...

A team of researchers at Georgia Institute of Technology (Georgia Tech), led by Yuhang Hu, PhD, has developed a new class of synthetic polymers that can grow, shrink, heal, and regenerate after their ...

In a bid to treat blindness, Life Biosciences will try out potent cellular reprogramming technology on volunteers. When Elon Musk was at Davos last week, an interviewer asked him if he thought aging ...